Clinical trial data is crucial for registering drugs in Singapore as it provides evidence of safety, efficacy, and quality. The Health Sciences Authority (HSA) evaluates this data to ensure that new drugs meet regulatory standards, protecting public health and ensuring that therapeutic benefits outweigh potential risks before market approval.
